Prevalence of gp160 polymorphisms known to be related to decreased susceptibility to temsavir in different subtypes of HIV-1 in the Los Alamos National Laboratory HIV Sequence Data...

por Gartland, Margaret, Arnoult, Eric, Foley, Brian T, Lataillade, Max, Ackerman, Peter, Llamoso, Cyril, Krystal, Mark
Publicado 2021

Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense(®) Entry assay

por Gartland, Margaret, Zhou, Nannan, Stewart, Eugene, Pierce, Amy, Clark, Andrew, Ackerman, Peter, Llamoso, Cyril, Lataillade, Max, Krystal, Mark
Publicado 2020

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

por Rose, Ronald, Gartland, Margaret, Li, Zhufang, Zhou, Nannan, Cockett, Mark, Beloor, Jagadish, Lataillade, Max, Ackerman, Peter, Krystal, Mark
Publicado 2022

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected...

por Morales-Ramirez, Javier, Bogner, Johannes R., Molina, Jean-Michel, Lombaard, Johan, Dicker, Ira B., Stock, David A., DeGrosky, Michelle, Gartland, Margaret, Pene Dumitrescu, Teodora, Min, Sherene, Llamoso, Cyril, Joshi, Samit R., Lataillade, Max
Publicado 2018

GSK983: A novel compound with broad-spectrum antiviral activity

por Harvey, Robert, Brown, Kevin, Zhang, Qin, Gartland, Margaret, Walton, Leslie, Talarico, Christine, Lawrence, Wendell, Selleseth, Dean, Coffield, Neil, Leary, Jeffry, Moniri, Kelly, Singer, Sara, Strum, Jay, Gudmundsson, Kristjan, Biron, Karen, Romines, Karen R., Sethna, Phiroze
Publicado 2009

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1

por Aberg, Judith A., Shepherd, Bronagh, Wang, Marcia, Madruga, Jose V., Mendo Urbina, Fernando, Katlama, Christine, Schrader, Shannon, Eron, Joseph J., Kumar, Princy N., Sprinz, Eduardo, Gartland, Margaret, Chabria, Shiven, Clark, Andrew, Pierce, Amy, Lataillade, Max, Tenorio, Allan R.
Publicado 2023

Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1

por Gartland, Margaret, Cahn, Pedro, DeJesus, Edwin, Diaz, Ricardo Sobhie, Grossberg, Robert, Kozal, Michael, Kumar, Princy, Molina, Jean-Michel, Mendo Urbina, Fernando, Wang, Marcia, Du, Fangfang, Chabria, Shiven, Clark, Andrew, Garside, Louise, Krystal, Mark, Mannino, Frank, Pierce, Amy, Ackerman, Peter, Lataillade, Max
Publicado 2022